Dose Escalation Study of CLR 131 in Children and Adolescents With Relapsed or Refractory Malignant Brain Cancer, Neuroblastoma, Rhabdomyosarcoma, Ewings Sarcoma, and Osteosarcoma
Conditions: Pediatric Solid Tumor; Pediatric Lymphoma; Pediatric Brain Tumor Intervention: Drug: CLR 131 Sponsor: Cellectar Biosciences, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Bone Cancers | Brain | Brain Cancers | Cancer | Cancer & Oncology | Cancer in Adolescents | Children | Ewing's Sarcoma | Lymphoma | Neuroblastoma | Neurology | Osteosarcoma | Pediatrics | Rhabdomyosarcoma | Sarcomas | Study